Thomas Looby, President & CEO at EKSO BIONICS HOLDINGS, INC. (EKSO), bought 15,000 shares at $1.13 ($17K) on 2017-09-08, disclosed to the SEC on 2017-09-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.